Five-year data shows lasting benefit for patients with advanced gastroesophageal cancers treated with nivolumab and chemotherapy.
Mary B. Daly, MD, PhD, from Fox Chase Cancer Center, discusses the proper timing for screening patients with a family history of cancer.
Hawaii recently allowed medical aid in dying for patients with terminal diseases, and other states may soon follow suit.
Cathy Belt, RN, MSN, AOCN, Abramson Cancer Center of the University of Pennsylvania, discusses possible steps individuals can take upon finding out they have an inherited cancer syndrome, such as mutations in the BRCA1 or BRCA2 genes.
Stephanie Gilbertson-White, PhD, APRN-BC, assistant professor, University of Iowa College of Nursing, discusses a pilot study that evaluated performance status, quality of life and survival in patients with advanced cancer who were referred to palliative care.
What group of our patients is diagnosed with a devastating illness in early childhood which gets increasingly worse with age and leads to debilitating pain which is both chronic and acute in nature?
Optune, a noninvasive device that delivers tumor-treating fields to the brain, had been found to improve efficacy compared to chemotherapy and is well-tolerated by patients with glioblastoma multiforme (GBM).
Jennifer Wenzel, PhD, RN, CCN, FAAN, discusses the importance of including minority patients in clinical trials
Ahead of his presentation at the 39th Annual Miami Breast Cancer Conference, Charles L. Loprinzi, MD, highlights some non-estrogenic approaches to hot flash management for patients with breast cancer.
Experts discuss optimizing renal cell carcinoma (RCC) treatment by integrating patient-reported outcomes and clinician insights.
Melisa Wong lays out the findings of a study she did looking at the age of patients with recurrent lung cancer and the likelihood they were to receive active treatment.
William Strauss, MD, Executive Director, Medical Affairs, AMAG Pharmaceuticals, Inc., discusses a study that analyzed mitigating oral mucositis symptoms in patients with head and neck cancers being treated with chemoradiation therapy.
Oncology nurses are crucial in the management of cancer symptoms and treatment-related adverse events.
Regina Cunningham, PhD, RN, NEA-BC, FAAN, discusses her career journey, which led her to become CEO of the Hospital of the University of Pennsylvania, and shares insights on how nurses can leverage their unique skills to assume leadership roles in healthcare.
The FDA has approved belantamab mafodotin-blmf (Blenrep) as a treatment for patients with relapsed/refractory multiple myeloma who have received 4 prior therapies, including an immunomodulatory drug, a proteasome inhibitor, and an anti-CD38 antibody.
Jason J. Luke, MD, an instructor in medicine atHarvard Medical School and a Medical Oncologist at the Dana-Farber Cancer Institute, explains why oncology nurses have such an important role in managing melanoma toxicities.
Reynaldo Garcia From Lineberger Comprehensive Cancer Center on CML BCR-ABL Testing Recommendation
Heidi Donovan, PhD, RN, comments on principles of symptom management that she believes need to be better implemented in clinical practice—particularly for patients with ovarian cancer.
Inadequate oversight has distorted the noble intent of the 340B Drug Pricing Program, transforming it into a perverse profit generator for many of America’s tax-exempt hospitals.
The update is in agreement with the FDA approval of a labeling supplement in June 2021 to the United States Prescribing Information for neratinib in HER2-positive breast cancer.
Anees Chagpar describes the oncology nurse's relationship between the patient and physician and gives some examples of important questions to be asking.
Carrie Stricker from the Abramson Cancer Center of the University of Pennsylvania on the Efficacy of Survivorship Care Plans for Posttreatment Breast Cancer Survivors.
A new surgical method could help treat lymphedema, according to one expert.
Sabrina Mikan, PhD, RN, ACNS-BC, of Texas Oncology discusses the importance of measuring the sleep quality of patients and caregivers.
The first-in-human trial for tebentafusp findings are in, and they show promise for managing a patients side effects to it.
Amanda Yopp, NP, Clinical Nurse Educator, Takeda Oncology, discusses the challenges with treating patients with multiple myeloma.
Timothy Clyne, RN, Trinitas Regional Medical Center, discusses the COMFORT curriculum and end-of-life conversations.
Ishwaria Mohan Subbiah, MD, of MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials. Ishwaria Mohan Subbiah, MD, MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials.
Kathleen M. Madden, MSN, FNP-BC, AOCNP®, provides an overview of treatment of melanoma with new targeted therapies.